crisaborole

FDA Drug Profile — Eucrisa

Drug Details

Generic Name
crisaborole
Brand Names
Eucrisa
Application Number
NDA207695
Sponsor
Pfizer Ireland Pharmaceuticals Unlimited Company
NDC Codes
3
Dosage Forms
POWDER, OINTMENT
Routes
TOPICAL
Active Ingredients
CRISABOROLE

Indications and Usage

1 INDICATIONS AND USAGE EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. EUCRISA is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. ( 1 )